Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03533283 |
Title | An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies |
Obinutuzumab + Polatuzumab vedotin-piiq + RO7082859 + Tocilizumab |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | ESP | BEL |